new warning about the risk of congestive heart failure with Sporanox (itraconazole)
June 2001
The FDA has just added a new warning about the risk of congestive heart failure with Sporanox (itraconazole).
There are now over 50 cases of Sporanox patients developing CHF.
Watch for patients who have cardiac problems or CHF and get Sporanox for fungal nail infections. Suggest Lamisil (terbinafine) instead...so far it hasn't been reported to cause cardiac problems.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote